Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA377169
Max Phase: Preclinical
Molecular Formula: C20H21ClN4O2
Molecular Weight: 384.87
Molecule Type: Small molecule
Associated Items:
ID: ALA377169
Max Phase: Preclinical
Molecular Formula: C20H21ClN4O2
Molecular Weight: 384.87
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)c1c(NC(=O)Nc2ccccc2Cl)c(=O)n(-c2ccccc2)n1C
Standard InChI: InChI=1S/C20H21ClN4O2/c1-13(2)18-17(23-20(27)22-16-12-8-7-11-15(16)21)19(26)25(24(18)3)14-9-5-4-6-10-14/h4-13H,1-3H3,(H2,22,23,27)
Standard InChI Key: NYMNKQKVDUIVME-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 384.87 | Molecular Weight (Monoisotopic): 384.1353 | AlogP: 4.60 | #Rotatable Bonds: 4 |
Polar Surface Area: 68.06 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 11.52 | CX Basic pKa: | CX LogP: 3.55 | CX LogD: 3.55 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.69 | Np Likeness Score: -1.62 |
1. Bürli RW, Xu H, Zou X, Muller K, Golden J, Frohn M, Adlam M, Plant MH, Wong M, McElvain M, Regal K, Viswanadhan VN, Tagari P, Hungate R.. (2006) Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents., 16 (14): [PMID:16697190] [10.1016/j.bmcl.2006.04.068] |
2. Frohn M, Xu H, Zou X, Chang C, McElvaine M, Plant MH, Wong M, Tagari P, Hungate R, Bürli RW.. (2007) New 'chemical probes' to examine the role of the hFPRL1 (or ALXR) receptor in inflammation., 17 (23): [PMID:17920884] [10.1016/j.bmcl.2007.09.043] |
Source(1):